Rexahn Pharmaceuticals to receive drug delivery patent; New radiation system cleared in Japan;

> Rexahn Pharmaceuticals announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office. The patent will cover Rexahn's Polymeric Systems for the Delivery of Anticancer Drugs. Release

> Japan's Ministry of Health issued a clearance for the Elekta Versa HD advanced radiation treatment system. Elekta touts the product's tumor-targeting technologies. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.